Welcome to the Flynn Forum
Events
Education & Training
Service Support
Patient-focused resources and materials designed to improve decision-making and support service improvement across a number of therapy areas. Developed with clinicians, NHS leaders and the third sector.
Products
About Flynn Pharma
The Flynn Forum engages healthcare professionals from across the clinical setting, offering continued professional development and service improvement through education rich meetings, resource items and service innovations.
Our Community Sites
Our General Medicine
Community
A resource centre for clinicians working across many therapy areas including information and resources regarding treatment and prevention of vitamin D deficiency in adults.
Our NDD
Community
A resource centre for healthcare professionals working in neurodevelopmental disorders such as attention deficit hyperactivity disorder, autism spectrum disorder, and learning disabilities.
Our Women's Health
Community
A resource centre for healthcare professionals working in women’s health, including menopause, HRT and contraception.
Become a Flynn Forum Member
Notifications
Notifications
Notification of new items added to the community.
Easy Access
Easy Access
Single-click for download, without having to re-enter details.
Printed Resources
Printed Resources
Option for having hard copies of patient leaflets delivered on request direct to your door.
Bookmark Content
Bookmark Content
Use of 'Bookmarks' on items you wish to revist.
Networking
Networking
Potential involvement in Peer Group Activities.
Track CPD
Track CPD
Personal history of activities downloadable in report form for your CPD.
Latest Events
Featured Event
‘Dyspepsia: To Refer or Not to Refer?’
Request A Meeting
Send a virtual meeting request
Latest Education & Training
Flynn works across a number of complex yet treatable therapy areas and is committed to supporting the continued education of healthcare professionals, trainees and allied roles.
Slenyto (prolonged-release melatonin) Treatment Algorithm
This treatment decision algorithm allows healthcare professionals to personalise titration of Slenyto to optimal dose.
Treatment success is attained by achieving one or more of the following:
Information for Parents of Children Prescribed Meflynate® XL (Methylphenidate Hydrochloride)
Information for parents of children prescribed Meflynate XL - a general guide to treatment with Meflynate XL.
Slenyto® (Prolonged release melatonin) Placebo Dose Card
A paediatric dose card illustrating the range of presentations for Slenyto®
To request this material please contact us.
Integrated Care Pathway (ICP)
An Integrated Care Pathway document for the management of ADHD patients throughout their ADHD journey. Created in association with UK healthcare professionals to guide the patient journey through their ADHD diagnosis.
ADHD Avatar - The Virtual Patient
A training resource for psychiatrists to facilitate identification of adult ADHD. Flynn Pharma, in conjunction with Virtual Health Shed, has developed 3D characters in a virtual environment to simulate interaction between the learner and a virtual patient or clinical virtual actor (avatar). Interaction with the computer generated characters is possible via multiple choice questions and, at the end of the consultation, the learner is provided with comprehensive feedback. The aim of this resource is to familiarise the learner with the 'language of ADHD' so as to be able to confidently identify adult ADHD patients presenting in secondary care.
For further information on the virtual patient please contact support@flynnpharma.com.
